Dr. Andrew Sproul, NYSCF Staff Scientst, presented the NYSCF Alzheimer's disease research team's latest research at the Alzheimer's Disease Resource Center's "What You Need to Know About Alzheimer's" event in East Hampton.
Dr. Sproul shared the NYSCF Alzheimer's team's recent discoveries and explained NYSCF's participation in large scale Alzheimer's initiatives through new Alzheimer's disease research consortia.
The event was held at the Jewish Center of the Hamptons in East Hampton on January 12th.
Dr. Gaby Maimon, a NYSCF – Robertson Neuroscience Investigator at The Rockefeller University, has been named a recipient of the Presidential Early Career Award for Scientists and Engineers. This award is the highest honor bestowed by the United States Government on science and engineering professionals in the early stages of their independent research careers.
Dr. Maimon focuses his research on the neural behavior in the fruit fly with implications on human cognitive function and learning.
Dr. Scott Noggle, Director of the NYSCF Laboratory and The NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease, presented his latest research at the 7th Annual Takeda Science Foundation Symposium on Pharmasciences in Osaka, Japan.
In addition to giving a talk on his latest Alzheimer's research, Dr. Noggle was awarded an "Excellent Poster Award" prize for his excpetional research poster display.
This conference is organized by Nobel Laureate Shinya Yamanaka, who won the Nobel Prize in 2012 for his part in the discovery of induced pluripotent stem (iPS) cells and the ability to reprogram cells into an embryonic-like state.
NBC News highlighted NYSCF's new partnership with the NIH Undiagnosed Disease Program (UDP), interviewing the father of two young girls who are patients in the UDP.
The sisters each suffer from unique genetic mutations causing a different rare disease in each sibling. Their father spoke about the UDP and the collaboration with NYSCF as a hopeful new avenue to more information on rare and undiagnosed diseases potentially leading to future treatments and cures.
On October 2nd, in honor of World Stem Cell Day, NYSCF scientists visited over 200 students at the Harlem Children's Zone's Promise Academies One and Two, introducing students to the fascinating world of scientific, specifically stem cell, research.
A group of students from the Promise Academies later toured the NYSCF Laboratory and talked with NYSCF scientists about their cutting-edge research.
These were exceptional days and future events already planned at these and many other New York schools. This ongoing educational outreatch program is an exciting NYSCF initiative that seeks to provide educational opportunities for young people and introduce them science and stem cell research.
The NYSCF Academy, including these educational outreach programs, is an ongoing education initiative to bring stem cell science education to middle and high school students throughout the greater New York City area in order to promote scientific literacy, educate young people on the promise of stem cell research, and encourage students to study science and technology.
The program deploys NYSCF scientists into local schools to provide seminars on stem cell biology and engage students in thoughtful discussion about stem cell research and its promise for the future. Students have the opportunity to meet the scientists and ask questions, both about stem cell research and life as a scientist.
On October 11th, NYSCF CEO and Co-founder Susan L. Solomon participated on a panel at the Hamptons international Film Festival discussing 'Decoding Annie Parker,' a film that portrays the struggles of two women - one a geneticist researching the still-unknown link between DNA and cancer among skeptical colleagues and the other, a breast cancer patient who has already lost her mother and sister to the disease - at the center of a monumental breakthrough in medical science. The panel discussed the patenting of genes and the development of personalized treatments.
NYSCF Scientist Dieter Egli, PhD, spoke about his work on curing mitochondrial disease with NPR on October 9th. He discussed the scientific techniques he and his team developed to avoid a mother passing on mitochondrial diseases to her biological children and the very real possibility of eliminating these rare and devastating diseases from the population as a whole.
NYSCF is working towards discovering and moving successful stem cell therapeutics to the clinic. CEO and co-founder Susan L. Solomon will bring her expertise and drive for this cause to the board of the Centre for Commercilaization of Regenerative Medicine (CCRM). CCRM is a Canadian not-for-profit organization supporting the development of foundational technologies that accelerate the commercialization of stem cell and biomaterials-based products and therapies.